Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses.

Abstract

Substances with digoxin- and ouabain-like immunoactivity (DLIA) are specific inhibitors of Na(+)-K(+)-ATPase which increase the total amount of intracellular stored calcium (Ca2+i). In diabetic patients, DLIA levels have been reported to be increased. Although this increase is probably secondary to sodium retention and volume expansion (included in diabetic… (More)

Topics

Cite this paper

@article{Martinka1997EndogenousDI, title={Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses.}, author={Emil Martinka and P Galajada and M Ochodnick{\'y} and Branislav Lichardus and Stefan Straka and Michal Mok{\'a}ň}, journal={Medical hypotheses}, year={1997}, volume={49 3}, pages={271-5} }